摘要目的 研究基因转染血管生成抑制对兔耳增生性瘢痕组织血管及其相关因子表达的影响.方法 将基因重组血管抑制剂Ad-METH-1作用于兔耳增生性瘢痕,用微循环显微镜检、组织学染色、免疫组织化学染色等方法,研究Ad-METH-1对兔耳瘢痕组织增生、血管生成及血管内皮细胞生长因子(vascular endothelial cell growth factor,VEGF)、碱性成纤维细胞生长因子(basic fibroblast growth factor,bFGF)表达的影响,探讨基因转染血管生成抑制对增生性瘢痕的影响.结果 Ad-METH-1注射后30 d,实验组瘢痕组织微血管计数为12.38±2.56,VEGF阳性细胞百分比为17.64%,bFGF阳性细胞为18.24%;对照组微血管计数为48.12±6.46,VEGF阳性细胞百分比为31.34%,bFGF阳性细胞为28.26%.结果 显示,实验组瘢痕组织微血管计数低于对照组,两组间差异有统计学意义(P＜0.01);实验组瘢痕组织VEGF及bFGF的阳性细胞百分比均低于对照组,两组间差异有统计学意义(P＜0.05).结论 Ad-METH-1对兔耳瘢痕组织增生、血管生成及VEGF、bFGF表达产生了明确的抑制作用,早期行血管抑制治疗可抑制增生性瘢痕的形成.基因转染血管抑制治疗有望成为一种有效的增生性瘢痕防治方法.

abstractsObjective To investigate the influence of gene transfection antiangiogenesis on microvessel and relative cytokine of hypertrophic scar of rabbits' ear.Methods The hypertrophic scar of rabbtis' ear was reproduced.On the 10th day after epithelization,Ad-METH-1 was injected into tissue of scar.30 days later,the microvessel of scar-tissue was detected by microcirculation microscope.Meanwhile.H&E and immunohistochemical stains were performed.Then the results were analyzed.Results 30 days after Ad-METH-1 injection.in experimental groups,the microvascular count of scar tissue was 12.38±2.56,the percentage of VEGF positive cells was 17.64%,and the percentage of bFGF positive cell was 18.24%:while in the control groups,the microvascular count of scar tissue was 48.12±6.46.the percentage of VEGF positive cell was 31.34%.and the percentage of bFGF positive eell was 28.26%.Results revealed that the count of microvessel of scar tissue in the experimental groups was lower than that in the control groups,between which there was the difference in statistics(P＜0.01).and that the percentage of VEGF and bFGF positive cells of scar tissue in the expenmental groups were lower than that in the control groups.between which there was the difference in statistics(P＜0.05).Conclusion Ad-METH-1 has marked inhibitory effects on scar tissue hyperplasia of rabbits' ear,angiogenesis and expression of VEGF and bFGF.Using antiangiogenesis therapy at the early phase could inhibit the formation of hypertrophic scar.Gene transfection antiangiogenesis therapy could bid fair to become an effective method to prevent and treat hypertrophic scar.